GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers

Autor: Duplessis, Christopher, Clarkson, Kristen A., Ross Turbyfill, K., Alcala, Ashley N., Gutierrez, Ramiro, Riddle, Mark S., Lee, Tida, Paolino, Kristopher, Weerts, Hailey P., Lynen, Amanda, Oaks, Edwin V., Porter, Chad K., Kaminski, Robert
Zdroj: In Vaccine August 2023
Databáze: ScienceDirect
Externí odkaz: